Chris Tovey
Equibles does not estimate personal net worth.
Get an email with a short summary when Jazz Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get JAZZ alertsAbout Chris Tovey
Chris Tovey is recorded as COO at Jazz Pharmaceuticals plc (JAZZ). The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $4,168,001 for Chris Tovey in fiscal 2021, including a base salary of $366,576. Jazz Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jazz Pharmaceuticals plc includes Bruce Cozadd (CEO and Board Member), Renee D. Gala (CEO), Renee Gala (CEO, COO and Board Member) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Jazz Pharmaceuticals plc
- Bruce Cozadd CEO, Board Member
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Matthew P. Young CFO
- Philip Johnson CFO
- Renée D. Galá CFO
- Renée Galá COO
- Neena M. Patil General Counsel
- Patricia Carr Chief Accounting Officer
- Anne O’Riordan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Jazz Pharmaceuticals plc (JAZZ) | Executive Vice President and Chief Operating Officer and Managing Director, Europe and International | $366,576 | $4,168,001 |
Recent activity
No call appearances or filed executive changes recorded yet.